Stay updated on Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Sign up to get notified when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.

Latest updates to the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe record history adds a new revision entry labeled v3.6.6 and notes the removal of v3.6.5. This reflects an update to the page's revision history.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history, replacing the previous v3.6.4. This reflects an update to the record rather than a substantive change to the study content.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed, reflecting an update to the record-keeping/versioning of the entry.SummaryDifference0.1%

- Check76 days agoChange DetectedA new revision entry (v3.6.3) was added to the study's record history. This update replaces the previous revision (v3.6.2) and reflects a subsequent update to the record.SummaryDifference0.1%

- Check83 days agoChange DetectedA new revision entry, v3.6.2, was added to the study record history and the prior revision entry, v3.6.0, was removed, reflecting an update to the record's revision history.SummaryDifference0.1%

- Check97 days agoChange DetectedThe study's record history update designates Scott T. Aaronson, M.D. as the last verifier and adds explicit 'Last verified' and 'Last known status was' labels for the v3.6.0 revision, replacing the prior verifier and revision details from v3.5.5.SummaryDifference2%

Stay in the know with updates to Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin Safety & Efficacy in BP-II Depression Clinical Trial page.